We invest in
companies
to catalyze their growth
adMare has helped build 36 companies, of which 25 are still active. These companies have attracted $2.4 billion of risk capital, have a combined value of $5.7 billion, and have created around 1,000 jobs in Canada.
Discover our companies below.
The companies we've helped build have grown under adMare's guidance and support, encompassing both financial backing and business development.
Inversago Pharma
Website
www.inversago.com
Email
info@inversago.com
LinkedIn
Visit our page
Line of business
Therapeutics - Metabolic
Description
Inversago Pharma is a clinical-stage, biotech company aiming to provide new treatment options that improve the lives of patients affected by metabolic conditions such as Prader-Willi Syndrome (PWS), non-alcoholic steatohepatitis (NASH), type 1 diabetes (T1D) and diabetic nephropathy.
More information
- Inversago Pharma to present at upcoming Bloom Burton & Co. Healthcare Investor Conference to be held on May 2-3, 2022 in Toronto, ON
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial
- Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and Provides Strategy Update
Back to list
Newsletter
Stay up to date on the
latest adMare news
Vancouver Innovation Centre
2405 Wesbrook Mall
Vancouver, British Columbia, Canada
V6T 1Z3
T. 604.827.1147
Toronto Office
MaRS Centre, West Tower
661 University Ave., Suite 405
Toronto, Ontario, Canada
M5G 1M1
T. 416.673.8100
Montreal Innovation Centre
7171 Frederick-Banting
Montréal, Québec, Canada
H4S 1Z9
